Effect of orlistat on coronary heart disease risk in obese patients with hypertension and/or hyperlipidaemia

被引：0
|
作者：
Lindgärde, F [1 ]
机构：
[1] Malmo Univ Hosp, Dept Vasc Dis, Malmo, Sweden
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2304
引用
收藏
页码：438 / 438
页数：1
相关论文
共 50 条
  • [31] Effect of coronary risk factors on coronary angiographic morphology in patients with ischemic heart disease
    Kasaoka, S
    Okuda, F
    Satoh, A
    Miura, T
    Kohno, M
    Fujii, T
    Katayama, K
    Ogawa, H
    Matsuzaki, M
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1997, 61 (05): : 390 - 395
  • [32] Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy
    Huang, Cheng-Chiao
    Wang, Weu
    Chen, Ray-Jade
    Wei, Po-Li
    Tzao, Ching
    Chen, Ping-Ling
    [J]. WORLD JOURNAL OF SURGERY, 2018, 42 (07) : 2173 - 2182
  • [33] Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy
    Cheng-Chiao Huang
    Weu Wang
    Ray-Jade Chen
    Po-Li Wei
    Ching Tzao
    Ping-Ling Chen
    [J]. World Journal of Surgery, 2018, 42 : 2173 - 2182
  • [34] How to Treat Hypertension in Patients With Coronary Heart Disease
    Moser, Marvin
    Wright, Jackson T., Jr.
    Victor, Ronald G.
    Handler, Joel
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (05): : 390 - 397
  • [35] ERGOMETRY IN PATIENTS WITH CORONARY HEART-DISEASE AND HYPERTENSION
    FRANZ, IW
    [J]. MEDIZINISCHE WELT, 1988, 39 (08): : 230 - 240
  • [36] Management of Hypertension among Patients with Coronary Heart Disease
    Olafiranye, Oladipupo
    Zizi, Ferdinand
    Brimah, Perry
    Jean-Louis, Girardin
    Makaryus, Amgad N.
    McFarlane, Samy
    Ogedegbe, Gbenga
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2011, 2011
  • [37] The impact of orlistat on the multifactorial risk profile of abdominally obese patients
    Despres, JP
    [J]. DIABETES, 1999, 48 : A307 - A307
  • [38] Orlistat (xenical®) reduces cardiovascular disease risk factors in obese patients with type 2 diabetes
    Hollander, P
    Lucas, C
    Segal, KR
    [J]. DIABETOLOGIA, 1998, 41 : A126 - A126
  • [39] Characteristics of coronary arterial lesions in patients with coronary heart disease and hypertension
    Zhang, Jing-Xia
    Dong, Hong-Zhi
    Chen, Bing-Wei
    Cong, Hong-Liang
    Xu, Jing
    [J]. SPRINGERPLUS, 2016, 5
  • [40] Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient
    H. Nägele
    B. Petersen
    U. Bonacker
    W. Rödiger
    [J]. European Journal of Clinical Pharmacology, 1999, 55 : 667 - 669
12345